Carlyle Group Inc. INFORMATION TABLE, Q3 FY2021

SEC Form 13F Information Table Summary

Business Context and Reporting Period

This filing is a Form 13F Information Table submitted by Carlyle Group Inc. for the reporting period ending September 30, 2021. The document discloses equity securities held by the investment manager at the end of the quarter. It does not contain financial performance data for Carlyle Group Inc. itself, but rather a list of its external equity holdings.

Key Financial Metrics and Holdings

The filing details specific equity positions held by the manager. The total value of the listed holdings in this excerpt is approximately $413.6 million. The table provides the number of shares, value (in thousands), and voting authority for each issuer.

Issuer Title of Class Shares (x$1000) Value ($) Voting Authority
Ortho Clinical Diagnostics H Ord Shs 2,182,599 118,106,000 Sole
Atotech Ltd Com 2,266,263 93,841,130 Sole
Atotech Ltd Com 1,444,932 59,831,573 Shared
ZoomInfo Technologies Inc Com Cl A 3,717,627 60,755,473 Sole
PPD Inc Com 2,607,267 55,722,733 Sole
Life Healthcare Inc Com 275,657 13,612,681 Sole
Vitru Ltd Com 99,944 6,246,471 Shared
Onesmart Intl Ed Group Ltd Sponsored Ads 3,851 7,860,000 Shared
Talos Energy Inc Com 32,020 2,325,337 Sole
Seacor Marine Hldgs Inc Com 5,315 1,147,989 Sole
SiriusPoint Ltd Com 1,198 129,408 None

Note: The filing text does not provide aggregate revenue, profit, cash flow, or debt metrics for Carlyle Group Inc. as this is a holdings disclosure, not a financial statement.

Material Changes and Guidance

The filing text does not provide comparative data against the prior period (June 30, 2021), nor does it include management commentary, guidance, outlook, or risk factors. The document strictly lists holdings as of the reporting date.

Investor Verification Checklist

  • Portfolio Concentration: Verify if the listed holdings represent the full portfolio or a partial excerpt, as Form 13F filings often contain multiple pages.
  • Voting Authority: Note the distinction between "Sole," "Shared," and "None" voting authority, particularly for Atotech Ltd and Vitru Ltd where shared authority exists.
  • Valuation Timing: Confirm that the values reflect market prices as of September 30, 2021, and do not reflect subsequent market movements.
  • Issuer Specifics: Investigate the specific business segments of the top holdings (e.g., Ortho Clinical Diagnostics, ZoomInfo) to understand sector exposure.